Skip to main content
Podcasts

Evolving Roles of KRAS Inhibitors in CRC


Van Morris, MD, University of Texas MD Anderson Cancer Center, Houston, discusses the evolving roles of KRAS inhibitors in colorectal cancer (CRC) at the 2022 Great Debates and Updates in Hematologic Malignancies meeting.

Disclaimer: The views and opinions expressed are those of the author(s) and do not necessarily reflect the official policy or position of Oncology Learning Network or HMP Global, their employees, and affiliates. Any content provided by our bloggers or authors are of their opinion and are not intended to malign any religion, ethnic group, club, association, organization, company, individual, anyone, or anything.